Cancer immunotherapy with STING agonist and PD-1 immune checkpoint inhibitor effectively suppresses peritoneal carcinomatosis of colon cancer

被引：0
|
作者：
Kim, C. [1 ]
Kim, W. [1 ]
Hang, Y. [2 ]
Kim, J. [1 ]
Chon, H. [1 ]
机构：
[1] CHA Univ, Seongnam Si, South Korea
[2] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 131
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Combination of IFN-gamma with STING agonist and PD-1 immune checkpoint blockade: a potential immunotherapy for gastric cancer
    Hosseinzadeh, Shahnaz
    Imani, Mahsa
    Pourfarzi, Farhad
    Jafari, Narjes
    Abediankenari, Saeid
    Safarzadeh, Elham
    [J]. MEDICAL ONCOLOGY, 2024, 41 (05)
  • [2] STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer
    Lee, Seung Joon
    Yang, Hannah
    Kim, Woo Ram
    Lee, Yu Seong
    Lee, Won Suk
    Kong, So Jung
    Lee, Hye Jin
    Kim, Jeong Hun
    Cheon, Jaekyung
    Kang, Beodeul
    Chon, Hong Jae
    Kim, Chan
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (06)
  • [3] Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer
    Lee, Yu Seong
    Lee, Won Suk
    Kim, Chang Woo
    Lee, Seung Joon
    Yang, Hannah
    Kong, So Jung
    Ning, John
    Yang, Kyung-Mee
    Kang, Beodeul
    Kim, Woo Ram
    Chon, Hong Jae
    Kim, Chan
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [4] Cancer immunotherapy and the PD-1/PD-L1 checkpoint pathway
    Barclay, Jonathan
    Creswell, Joanne
    Leon, Juan
    [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (04): : 393 - 399
  • [5] Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges
    Javed, Sadique A.
    Najmi, Asim
    Ahsan, Waquar
    Zoghebi, Khalid
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [6] Dostarlimab: A promising new PD-1 inhibitor for cancer immunotherapy
    Farzeen, Zubaria
    Khan, Rana Rashad Mahmood
    Chaudhry, Ayoub Rashid
    Pervaiz, Muhammad
    Saeed, Zohaib
    Rasheed, Shahzad
    Shehzad, Behram
    Adnan, Ahmad
    Summer, Muhammad
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [7] 15-PGDH regulated PD-1/PD-L1 immune checkpoint blockade immunotherapy in colon cancer is a TNF-α dependent phenomenon
    Satapathy, S.
    Sjolander, A.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 107 - 107
  • [8] Tumor Ablation by Irreversible Electroporation Augments PD-1 Checkpoint Inhibitor Immunotherapy in Colon Adenocarcinoma
    Slaughter, Joseph
    Shao, Qi
    Jiang, Minhan
    Bischof, John
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S257 - S257
  • [9] STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer
    Abdi Ghaffari
    Nichole Peterson
    Kasra Khalaj
    Natasha Vitkin
    Andrew Robinson
    Julie-Ann Francis
    Madhuri Koti
    [J]. British Journal of Cancer, 2018, 119 : 440 - 449
  • [10] STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer
    Ghaffari, Abdi
    Peterson, Nichole
    Khalaj, Kasra
    Vitkin, Natasha
    Robinson, Andrew
    Francis, Julie-Ann
    Koti, Madhuri
    [J]. BRITISH JOURNAL OF CANCER, 2018, 119 (04) : 440 - 449
12345